Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells
出版年份 2015 全文链接
标题
Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells
作者
关键词
Colon cancer, Anti-proliferation, GRP78, 17-DMAG, Hsp90
出版物
TUMOR BIOLOGY
Volume 36, Issue 6, Pages 4367-4376
出版商
Springer Nature
发表日期
2015-01-25
DOI
10.1007/s13277-015-3076-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma
- (2014) Ji-Hee Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antiproliferative Effect of HSP90 Inhibitor Y306zh Against Pancreatic Cancer is Mediated by Interruption of AKT and MAPK Signaling Pathways
- (2014) Nina Xue et al. CURRENT CANCER DRUG TARGETS
- Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer
- (2014) Lei Yang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism
- (2014) Jaime Acquaviva et al. MOLECULAR CANCER RESEARCH
- Store-Operated Ca2+ Entry (SOCE) Regulates Melanoma Proliferation and Cell Migration
- (2014) Masanari Umemura et al. PLoS One
- Silencing survivin activates autophagy as an alternative survival pathway in HCC cells
- (2014) Yu-Jia Chang et al. TUMOR BIOLOGY
- Colorectal cancer: From prevention to personalized medicine
- (2014) Gemma Binefa WORLD JOURNAL OF GASTROENTEROLOGY
- Advances and new perspectives in the treatment of metastatic colon cancer
- (2014) Gonzalo Jr Recondo World Journal of Gastrointestinal Oncology
- Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth
- (2013) Li-Jen Kuo et al. JOURNAL OF SURGICAL RESEARCH
- Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
- (2013) Kan He et al. MOLECULAR CANCER THERAPEUTICS
- Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression
- (2013) Chun-Te Wu et al. TUMOR BIOLOGY
- Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells
- (2013) Cheng-Jeng Tai et al. TUMOR BIOLOGY
- Recent Advances in Hsp90 Inhibitors as Antitumor Agents
- (2012) S. Messaoudi et al. Anti-Cancer Agents in Medicinal Chemistry
- Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
- (2012) L. Neckers et al. CLINICAL CANCER RESEARCH
- The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
- (2012) Verena Jendrossek CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The network interaction of the human cytosolic 90kDa heat shock protein Hsp90: A target for cancer therapeutics
- (2012) Viviane C.H. da Silva et al. Journal of Proteomics
- A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors
- (2011) Simon Pacey et al. CLINICAL CANCER RESEARCH
- Adjuvant treatment of colon cancer: what is next?
- (2011) Katherine Van Loon et al. CURRENT OPINION IN ONCOLOGY
- Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
- (2010) Yu-Jia Chang et al. ANNALS OF SURGICAL ONCOLOGY
- 17-DMAG targets the nuclear factor- B family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
- (2010) E. Hertlein et al. BLOOD
- Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
- (2010) Christina Hackl et al. BMC CANCER
- GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy
- (2010) Eunjung Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
- (2010) J E Lancet et al. LEUKEMIA
- Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma
- (2009) Jeng-Fong Chiou et al. ANNALS OF SURGICAL ONCOLOGY
- Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders
- (2009) Miao Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
- (2009) Shivaani Kummar et al. EUROPEAN JOURNAL OF CANCER
- Tanespimycin: the opportunities and challenges of targeting heat shock protein 90
- (2009) Charles Erlichman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response
- (2009) Jiao Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
- (2008) Marissa V. Powers et al. CANCER CELL
- Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives
- (2008) Y. Fukuyo et al. CANCER RESEARCH
- Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation
- (2008) Charbel El Boustany et al. HEPATOLOGY
- Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas
- (2008) Hua-chuan Zheng et al. HUMAN PATHOLOGY
- Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma
- (2008) Peter Hersey et al. Pigment Cell & Melanoma Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started